EPITOMEE MEDICAL LTD

As of June 30, 2026, EPITOMEE MEDICAL LTD carries a market capitalization of 20.43B, placing it among publicly traded companies globally. Its enterprise value stands at 19.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, EPITOMEE MEDICAL LTD has 30.18M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, EPITOMEE MEDICAL LTD maintains a current ratio of 3.87, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, EPITOMEE MEDICAL LTD's stock has declined approximately 43.80% over the past 52 weeks. The 50-day moving average sits at 345.83, while the 200-day moving average is 624.94.

As of June 30, 2026, EPITOMEE MEDICAL LTD holds 2.54B in cash and equivalents against 1.74B in total debt, resulting in a net debt position of -2.54B. Total book value stands at 6.33B, with working capital of 2.23B providing operational flexibility.